Advances in Preclinical Imaging Provide New Insights for Oncology Research
The tried and trusted imaging modalities in the preclinical researcher’s toolkit have undergone an evolution over recent years and a…
Read more
Statistically Speaking – Why a Hybrid of Centralised
Statistical Monitoring and Key Risk Indicators could be the Answer for Risk-based Monitoring The industry is at a crossroads when…
Quest for Outbreak Preparedness: Advancing Research Response to the Next Infectious Threat
Explosive human population growth and international travel, combined with a shrinking habitat for animal species and increased interaction between humans…
Accelerating the Pace of Study Start-up
Launching a new clinical study is an exciting stage of product development. There is tremendous hope that a new drug…
Safety in the Spotlight: A Risk-based Approach to Biosimilars
Biosimilars have important cost benefits to offer the overall healthcare system, and they give access to treatment for patients with…
Medical Management in Clinical Trials: A Roadmap to Operational Excellence
The clinical research physician is a key member of any drug development team and forms the backbone for all medical…
Medicinal Products for Human Use and Clinical Trials in the EU – A Changing Regulatory Landscape
Bringing new drug products from early discovery, through clinical trials and into commercialisation is a challenging, costly and time-consuming process.…
Entering the Era of Cognitive Computing
The concept of digital health is not new; a pioneer in radio and publishing, Hugo Gernsback, first put forward the…
What Makes Russia an Attractive Market for Conducting Clinical Trials?
Today’s Russian clinical trial market is worth 880 million dollars and there is every expectation that it will continue to…
A Review of FDA’s Action Plan to Proactively Reduce Prescription Opioid Abuse
The increasing rates of opioid abuse and dependence, as well as the alarming rise in the number of prescription opioid-related…